News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Amber Schilling, PharmD

Articles by Amber Schilling, PharmD

Navigating New Challenges in the Management of ADHD

ByAmber Schilling, PharmD

March 24th 2021

Multidisciplinary insights on helping patients with ADHD during the COVID-19 pandemic, medication abuse, and other factors affecting care.

Latest Updated Articles

Trending on Psychiatric Times

ADHD: Correcting Careless Myths

Tonmya Available Commercially for Treatment of Fibromyalgia

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

Making Chatbots Safe For Suicidal Patients

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

© 2025 MJH Life Sciences^®

All rights reserved.